SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 14th, 2019 • Intercept Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 14th, 2019 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is made and entered into as of May 8, 2019 (the “Effective Date”) by and among Intercept Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of Purchasers attached and incorporated by reference as Schedule I hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 10th, 2018 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 10th, 2018 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is made and entered into as of April 4, 2018 (the “Effective Date”) by and among Intercept Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of Purchasers attached and incorporated by reference as Schedule I hereto (each a “Purchaser” and together the “Purchasers”). Certain terms used and not otherwise defined in the text of this Agreement are defined in Section 11 hereof.